MIT scientists turn immune cells into cancer killers inside the body
MIT researchers reprogrammed donor NK cells inside living mice to eliminate lymphoma in three weeks without rejection.
7 trends tracked about this subject — the full history, oldest to newest below.
MIT researchers reprogrammed donor NK cells inside living mice to eliminate lymphoma in three weeks without rejection.
Research suggests seasonal influenza vaccines may activate immune responses against skin cancer tumors in early studies.
Marengo Therapeutics' Invikafusp alfa shows promise in treating TMB-H solid tumors resistant to standard immune checkpoint blockade.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Researchers have identified how the thymus-derived hormone thymulin can suppress age-related inflammation and potentially enhance cancer immunotherapy.
New research suggests creatine may extend its utility beyond muscle growth to support the immune system in fighting cancer.
Coverage from multiple industry outlets explores how engineered immune therapies and checkpoint inhibitors are transforming cancer treatment.